J Korean Gastric Cancer Assoc.  2003 Mar;3(1):19-25.

Expression of Survivin and HIAP-1 in Korean Gastric Cancers

Affiliations
  • 1Department of Surgery, Keimyung University School of Medicine, Daegu, Korea. sohnss@dsmc.or.kr
  • 2Department of Microbiology, Keimyung University School of Medicine, Daegu, Korea.

Abstract

PURPOSE: Dysregulation of apoptosis may attribute to development of cancer by abnormally prolonging cell viability with accumulation of transforming mutations. Survivin and HIAP (Human Inhibitors of Apoptosis)-1 were recently described as apoptosis inhibitors. Their pathogenic roles in gastric cancer are largely unknown. In the present study, we examined the expression of survivin and HIAP-1 in gastric cancer tissues and cell lines in order to elucidate the roles of survivin and HIAP-1 in the process of gastric carcinogenesis. MATENRIALS AND METHODS: Eight gastric cancer cell lines and five gastric cancer tissues were studied. The expression of survivin and HIAP-1 were evaluated by reverse transcription -polymerase chain reaction (RT-PCR), immunohistochemistry, and Western blot.
RESULTS
Western blot and RT-PCR analysis revealed survivin and HIAP-1 expression in all gastric cancer cell lines. Increased expression of survivin and HIAP-1 were found in all cases of gastric cancer tissues compared to normal tissues by Western blot analysis. In immunohistochemical analysis tumor cells were stained with anti-survivin and anti-HIAP-1 antibodies. Cell cycle dependence of survivin expression was preserved in gastric cancer cell lines.
CONCLUSION
The results indicate that increased expression of survivin and HIAP-1 genes may play an important role in gastric cancer.

Keyword

Gastric cancer; Survivin; HIAP-1

MeSH Terms

Antibodies
Apoptosis
Blotting, Western
Carcinogenesis
Cell Cycle
Cell Line
Cell Survival
Immunohistochemistry
Reverse Transcription
Stomach Neoplasms*
Antibodies
Full Text Links
  • JKGCA
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr